RMED Company Profile and Key Details

Ra Medical Systems, Inc. generated EPS of -$45.92 over the past year. Five-year average earnings growth is 56.92%. Ra Medical Systems, Inc. earnings surprise history is a mixed track record. The quarter that ended November 13, 2023, missed forecasts by 94278.09%. The prior quarter beat by -2600.0%. Over the last six quarters, Apple has recorded several small beats. These include -6.25% in August 15, 2022.

Our AI price prediction model suggests that Ra Medical Systems, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by September 13, 2024, within a range of $0.00 to $5.46.

Ra Medical Systems, Inc. (AMEX:RMED) shares are up 712.28% year-to-date Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Ra Medical Systems, Inc. trading at a premium to the broader market with a P/E of 0.21. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $12.25, suggesting 2030.43% upside.

Ra Medical Systems, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $11.53. This means the shares are trading below this model’s fair value.

Ra Medical Systems, Inc. (AMEX:RMED) closed at $0.59 USD, gaining $0.05 (10.00%) from the previous close of $0.54. The stock is currently mid-range between its 52-week high and low $0.48 and $11.13. With a market capitalization of about $3.84 million, Ra Medical Systems, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.00). Key stats such as the average daily volume over the past year has been around 290.93 thousand shares, volume is running light vs its 52-week average. Headquartered in Carlsbad, CA, Ra Medical Systems, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO David A. Jenkins, the company employs approximately 14 people and listed since September 27, 2018. Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases.

Ra Medical Systems, Inc. trades at a P/E ratio of 0.21, slightly below the S&P 500 average, with a price-to-sales ratio of 5.69 and a price-to-book ratio of 1.16 suggesting the stock is closer to book value. The P/FCF stands at -0.92, also below market averages.